These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
482 related items for PubMed ID: 22819543
1. Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation. Deguchi I, Ogawa H, Ohe Y, Nemoto M, Tanahashi N. J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):846-50. PubMed ID: 22819543 [Abstract] [Full Text] [Related]
2. The CHA(2)DS(2)-VASc score reflects clinical outcomes in nonvalvular atrial fibrillation patients with an initial cardioembolic stroke. Deguchi I, Hayashi T, Ohe Y, Kato Y, Nagoya H, Fukuoka T, Maruyama H, Horiuchi Y, Tanahashi N. J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e343-6. PubMed ID: 23523201 [Abstract] [Full Text] [Related]
3. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation . Maruyama K, Uchiyama S, Shiga T, Iijima M, Ishizuka K, Hoshino T, Kitagawa K. Cerebrovasc Dis Extra; 2017 Nov; 7(1):35-43. PubMed ID: 28253498 [Abstract] [Full Text] [Related]
4. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Tu HT, Campbell BC, Meretoja A, Churilov L, Lees KR, Donnan GA, Davis SM. Cerebrovasc Dis; 2013 Nov; 36(4):273-80. PubMed ID: 24135809 [Abstract] [Full Text] [Related]
5. Pre-admission CHADS2 score is related to severity and outcome of stroke. Sato S, Yazawa Y, Itabashi R, Tsukita K, Fujiwara S, Furui E. J Neurol Sci; 2011 Aug 15; 307(1-2):149-52. PubMed ID: 21570092 [Abstract] [Full Text] [Related]
6. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation. Matsumoto M, Sakaguchi M, Okazaki S, Furukado S, Tagaya M, Etani H, Shimazu T, Yoshimine T, Mochizuki H, Kitagawa K. Cerebrovasc Dis; 2013 Aug 15; 35(1):64-72. PubMed ID: 23428999 [Abstract] [Full Text] [Related]
7. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry. Wang C, Yang Z, Wang C, Wang Y, Zhao X, Liu L, Wang DZ, Li H, Wang Y. J Stroke Cerebrovasc Dis; 2014 Aug 15; 23(5):1157-63. PubMed ID: 24291013 [Abstract] [Full Text] [Related]
8. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation. Tanaka K, Yamada T, Torii T, Furuta K, Matsumoto S, Yoshimura T, Takase K, Wakata Y, Nakashima N, Kira J, Murai H. J Stroke Cerebrovasc Dis; 2015 Jul 15; 24(7):1629-35. PubMed ID: 25906940 [Abstract] [Full Text] [Related]
9. Low Body Mass Index is a Poor Prognosis Factor in Cardioembolic Stroke Patients with NonValvular Atrial Fibrillation. Hagii J, Metoki N, Saito S, Fujita A, Shiroto H, Sasaki S, Takahashi K, Hitomi H, Baba Y, Seino S, Kamada T, Uchizawa T, Iwata M, Matsumoto S, Yasujima M, Tomita H. J Stroke Cerebrovasc Dis; 2018 Nov 15; 27(11):3155-3162. PubMed ID: 30093200 [Abstract] [Full Text] [Related]
10. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L. Am J Geriatr Pharmacother; 2009 Jun 15; 7(3):159-66. PubMed ID: 19616184 [Abstract] [Full Text] [Related]
11. CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry. Koga M, Kimura K, Shibazaki K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Naganuma M, Nezu T, Maeda K, Minematsu K, Toyoda K. J Neurol Sci; 2011 Jul 15; 306(1-2):49-53. PubMed ID: 21492878 [Abstract] [Full Text] [Related]
12. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin. Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H. Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182 [Abstract] [Full Text] [Related]
13. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH. Arch Intern Med; 1996 Nov 11; 156(20):2311-6. PubMed ID: 8911237 [Abstract] [Full Text] [Related]
14. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation. Li S, Zhao X, Wang C, Liu L, Liu G, Wang Y, Wang C, Jing J, Wang YJ. J Stroke Cerebrovasc Dis; 2013 Nov 11; 22(8):e419-25. PubMed ID: 23721617 [Abstract] [Full Text] [Related]
15. Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation. Indredavik B, Rohweder G, Lydersen S. J Intern Med; 2005 Aug 11; 258(2):133-44. PubMed ID: 16018790 [Abstract] [Full Text] [Related]
16. [Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment]. García Escrivà A, López Hernández N, Hernández Lorido R, Oliver Navarrete C, Bustos S, Carneado Ruiz J, Gracia Fleta F, Moltó Jordá JM. Rev Neurol; 2005 Aug 11; 38(5):401-5. PubMed ID: 15029514 [Abstract] [Full Text] [Related]
19. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey. Marcucci M, Lip GY, Nieuwlaat R, Pisters R, Crijns HJ, Iorio A. Am J Med; 2014 Oct 11; 127(10):979-986.e2. PubMed ID: 24838192 [Abstract] [Full Text] [Related]
20. Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation. Deguchi I, Tanahashi N, Takao M. J Stroke Cerebrovasc Dis; 2018 Oct 11; 27(10):2627-2631. PubMed ID: 29970321 [Abstract] [Full Text] [Related] Page: [Next] [New Search]